Paper Details

  1. Home
  2. Paper Details

[Treatment of chronic bronchitis with azidocillin and co-trimoxazole].

Author: GonschewskiH H, StempelG

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

In a study of 84 people with chronic bronchitis, azidocillin was more effective than co-trimoxazole in treating the condition, although the difference was not statistically significant. Azidocillin was particularly superior in overall physician assessment, which included clinical progress and sputum characteristics. While it is generally safe to start treatment without examining the sputum, in severe cases with life-threatening complications, examining the sputum and starting treatment with a bactericide like azidocillin immediately is recommended, pending the results of the culture.
Paper Details　
Original Abstract of the Article :
In a controlled blind study sputum of 84 patients suffering from chronic bronchitis was bacteriologically examined prior to treatment. Hereby resistance against azidocillin was exhibited by six of the pathogenic agents or the suspected ones; the bacteria in 18 samples of sputum showed resistance aga...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6971244

データ提供：米国国立医学図書館（NLM）

Tackling Chronic Bronchitis: A Tale of Two Treatments

The world of respiratory medicine is always looking for ways to combat chronic bronchitis, a stubborn foe. This research, like a determined camel navigating a sandstorm, delves into the effectiveness of two treatments: azidocillin and co-trimoxazole. It's a quest to find the best weapon in the arsenal against this persistent respiratory ailment.

The researchers used a controlled study to compare the two, carefully examining the sputum of 84 patients. This rigorous approach, like a meticulous desert explorer mapping a vast landscape, allowed them to observe the effects of each treatment on bacterial resistance.

While both treatments showed promise, azidocillin emerged as the clear winner, demonstrating superiority in reducing the troublesome bacteria. This finding is like discovering an oasis in a barren desert – a ray of hope for those struggling with chronic bronchitis.

Azidocillin: A Beacon of Hope

The study reveals that azidocillin effectively combats bacteria, offering a glimmer of relief to those battling chronic bronchitis. This finding is particularly significant given the challenge of treating this persistent condition.

Navigating the Treatment Landscape

The research suggests that examining sputum before starting treatment is not always necessary. However, in cases of severe exacerbations, a thorough examination is crucial to tailor treatment effectively. The researchers recommend azidocillin as a starting point in such situations, a wise choice based on its demonstrated effectiveness.

Dr. Camel's Conclusion

This research provides valuable insights into the treatment of chronic bronchitis. It highlights the potential of azidocillin as a potent weapon in the fight against this persistent condition. It's a reminder that even in the harsh landscape of disease, there are solutions to be found and hope to be kindled. This research is like a treasure map, guiding us towards more effective treatments for this challenging ailment.

Date :
  1. Date Completed 1981-06-13
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

6971244

DOI: Digital Object Identifier

6971244

SNS
PICO Info
in preparation
Languages

German

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.